Thus, reduced SDF-1 secretion by prostate cancer cells after depletion of platelet SCF could result in diminished mPC3 tumor growth due to inhibition of angiogenesis through effects on the SDF-1/CXCR4 pathway. This evidence concerns the gene CXCR4 and prostate carcinoma.